About the
NeLM
|
Help & Support
|
Site Feedback
|
Update Newsletter Subscription
Homepage
Login
|
Register
Search the NeLM
Medicines A-Z
Find key information about medicines by name (prototype)
Browse by Categories:
BNF Category
|
Medical Specialty
|
National Health Service
|
Medicines Information
Browse by NeLM area:
Evidence
|
Other Library Updates
|
News
|
Health In Focus
|
Medicines A-Z
|
Communities
|
Useful Links
|
Formularies
Medicines Information
Adverse Drug Reactions
Clinical guidelines
Compliance
Drug Alerts
Drug Interactions
Drug reviews
Drug shortages
Drugs in lactation
Drugs in liver disease
Drugs in paediatrics
Drugs in pregnancy
Drugs in renal failure
FAQs
General Advice
Horizon scanning
Medication errors
Pharmaceutical Industry
Pharmaceutics
Product Discontinuation
Product Licence Changes
Toxicology & poisoning
Travel health
Unlicenced medicines
15124 library items
in Medicines Information
Filter results by:
Date Published
2012 (399)
2011 (3661)
2010 (3270)
2009 (2507)
2008 (2114)
More
NeLM
Area
News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies
Sort by:
Least recent publication date
Most recent publication date
Title alphabetical A-Z
Title alphabetical Z-A
Source alphabetical A-Z
Source alphabetical Z-A
Display summary:
No
Yes
Results 1 - 10 of 15124
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next
1.
Intravenous acetaminophen in the United States: iatrogenic dosing errors
Source:
Pediatrics
,
Date published:
09/02/2012
Category:
4.7.1 Non-opioid analgesics and compound analgesic preparations
|
Medication errors
|
Paediatrics
NeLM
Area:
Evidence
>
Medicines Management
>
References
Abstract link
2.
FDA Safety Communication: Proton pump inhibitors and Clostridium Difficile-associated diarrhoea
Source:
FDA
,
Date published:
09/02/2012
Category:
1.3.1 H2-receptor antagonists
|
1.3.5 Proton pump inhibitors
|
Adverse Drug Reactions
|
Bacterial
|
Food &Drug Administration (FDA)
|
Infection
NeLM
Area:
News
Link
3.
NICE issues draft guideline on assessing risk of fragility fracture in osteoporosis
Source:
NICE
,
Date published:
09/02/2012
Category:
Clinical guidelines
|
National Institute of Clinical Excellence (NICE)
|
Osteoporosis
NeLM
Area:
News
Link
4.
NICE issues draft guideline on management of an acute painful sickle cell episode
Source:
NICE
,
Date published:
09/02/2012
Category:
Clinical guidelines
|
Haematology
|
National Institute of Clinical Excellence (NICE)
|
Pain control
NeLM
Area:
News
Link
5.
NHS Choices assessment of press reports that 'economy class' DVT syndrome myth busted and new US guidelines on prevention of thrombosis
Source:
NHS Choices
,
Date published:
09/02/2012
Category:
2.8.2 Oral anticoagulants
|
2.9 Antiplatelet drugs
|
Travel health
|
Travel medicine
|
Venous Thromboembolism
NeLM
Area:
News
Link to guidance
Link to NHS Choices assessment
6.
Review: Selection of chronic hepatitis B therapy with high barrier to resistance
Source:
Lancet Infectious Diseases
,
Date published:
09/02/2012
Category:
5.3.3 Viral hepatitis
|
Drug reviews
|
Hepatitis and other gastrointestinal infections
NeLM
Area:
News
Abstract
7.
FDA to discuss license extension application for denosumab (Xgeva) to treat men with castration-resistant prostate cancer at high risk of developing bone metastases
Source:
BioSpace
,
Date published:
09/02/2012
Category:
Cancer: prostate
|
Food &Drug Administration (FDA)
|
Licence extension
|
Rheumatology
NeLM
Area:
News
Link
8.
Department of Health announces funding for new research into antibiotic-resistance bacteria
Source:
Department of Health (DH)
,
Date published:
09/02/2012
Category:
5.1 Antibacterial drugs
|
Department of Health (DH)
|
New drugs
|
Public Health
NeLM
Area:
News
Press release
Link to report
9.
Do medicines with the same or similar brand names contain identical active ingredients in different countries?
Source:
Wessex Drug and Medicines Information Centre
,
Date published:
09/02/2012
Review date:
28/02/2014
Category:
FAQs
|
General Advice
NeLM
Area:
Evidence
>
Medicines Q & A
FDA Public Health Advisory January 2006
10.
London Cancer New Drugs Group Rapid Review: Cabazitaxel for the second-line treatment of hormone-refractory metastatic prostate cancer
Source:
London Cancer New Drugs Group
,
Date published:
09/02/2012
Category:
8.1.5 Other antineoplastic drugs
|
Cancer: prostate
|
Drug reviews
NeLM
Area:
Evidence
>
Drug Specific Reviews
Cabazitaxel review
Results 1 - 10 of 15124
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next